Form 4: Impinj CEO Sells 10,000 Shares Under 10b5-1 Plan

Impinj Inc.'s CEO, Chris Diorio, sold 10,000 shares of common stock over two days in late August 2025, pursuant to a pre-arranged Rule 10b5-1 trading plan.

Summary

• Chris Diorio, Chief Executive Officer and Director of Impinj Inc. (PI), reported the sale of 10,000 shares of common stock.
• The transactions occurred on August 28, 2025, and August 29, 2025.
• The sales were executed under a Rule 10b5-1 trading plan, which became effective on May 28, 2025.
• Shares sold on August 28, 2025, included blocks at weighted-average prices of $185.9255 (1,112 shares), $186.7989 (784 shares), $188.1404 (1,749 shares), $189.0634 (960 shares), $190.3271 (325 shares), and $190.7886 (70 shares).
• Shares sold on August 29, 2025, included blocks at weighted-average prices of $188.3865 (2,000 shares), $189.3862 (2,800 shares), and $190.28 (200 shares).
• Following these transactions, Dr. Diorio directly beneficially owns 356,109 shares of common stock.
• Dr. Diorio also indirectly beneficially owns 199,362 shares through DFT L.L.C.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly negative. While insider selling can be a negative signal, the execution under a pre-arranged 10b5-1 plan mitigates the immediate concern of opportunistic trading, suggesting a planned diversification or liquidity event rather than a reaction to adverse company news.

Positives

• The sales were conducted under a pre-arranged Rule 10b5-1 trading plan, which indicates the transactions were scheduled in advance and not based on immediate, non-public information, thereby enhancing transparency and mitigating concerns about opportunistic insider trading.

Negatives

• The Chief Executive Officer and Director sold a significant number of shares (10,000), which could be perceived negatively by some investors, potentially signaling a belief that the stock is fairly valued or overvalued.

Risks

• Potential for negative investor sentiment or a temporary dip in stock price due to the perception of insider selling, despite the existence of a Rule 10b5-1 plan.

Management Comments

• The sales reported by Dr. Diorio were effected pursuant to a Rule 10b5-1 trading plan effective on May 28, 2025.

Corporate Governance

Related Party Transactions

• Chris Diorio indirectly beneficially owns 199,362 shares of common stock through DFT L.L.C.

Stakeholder Impact

• Shareholders may interpret the insider selling as a signal regarding management's view on the company's valuation or future prospects, potentially influencing their investment decisions.

Key Dates

Recommendation

The insider selling, while significant, was conducted under a pre-arranged Rule 10b5-1 plan, which suggests a planned financial event rather than a reaction to new, negative information. This mitigates the immediate bearish signal. Without additional financial or operational context, a 'hold' recommendation is appropriate, advising investors to monitor future company performance and broader market trends rather than reacting solely to this insider transaction.

Keywords

Impinj, PI, Insider Trading, Form 4, Stock Sale, CEO, Chris Diorio, 10b5-1 Plan, Equity Transaction